McIlrath & Eck’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.7K | Hold |
52
| – | – | ﹤0.01% | 523 |
|
|
2025
Q1 | $17.2K | Hold |
52
| – | – | ﹤0.01% | 503 |
|
|
2024
Q4 | $16K | Hold |
52
| – | – | ﹤0.01% | 526 |
|
|
2024
Q3 | $11K | Hold |
52
| – | – | ﹤0.01% | 611 |
|
|
2024
Q2 | $14.6K | Hold |
52
| – | – | ﹤0.01% | 524 |
|
|
2024
Q1 | $13.9K | Hold |
52
| – | – | ﹤0.01% | 549 |
|
|
2023
Q4 | $12K | Hold |
52
| – | – | ﹤0.01% | 522 |
|
|
2023
Q3 | $7.59K | Hold |
52
| – | – | ﹤0.01% | 583 |
|
|
2023
Q2 | $12K | Hold |
52
| – | – | ﹤0.01% | 534 |
|
|
2023
Q1 | $12.6K | Hold |
52
| – | – | ﹤0.01% | 506 |
|
|
2022
Q4 | $15.1K | Hold |
52
| – | – | ﹤0.01% | 457 |
|
|
2022
Q3 | $3K | Hold |
52
| – | – | ﹤0.01% | 719 |
|
|
2022
Q2 | $4K | Hold |
52
| – | – | ﹤0.01% | 650 |
|
|
2022
Q1 | $5K | Hold |
52
| – | – | ﹤0.01% | 638 |
|
|
2021
Q4 | $4K | Hold |
52
| – | – | ﹤0.01% | 662 |
|
|
2021
Q3 | $4K | Hold |
52
| – | – | ﹤0.01% | 653 |
|
|
2021
Q2 | $5K | Buy |
+52
| New | +$5K | ﹤0.01% | 623 |
|